Integrated Shoulder System

...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...

Medicine Products:

Vanadium Quantitation, Serum or Plasma Valley Fever IgM by ELISA Valley Fever by CF Valium

(Date:9/5/2008)...an be controlled, but you need to know what trigge...5 (HealthDay News) -- If you are one of the 36 mil... there is nowhere in the United States that is fre... report shows. , Allergies don,t only happen in...ns as well. In the fall, the most challenging citi...

(Date:9/5/2008)...ANKLIN, Mass., Sept. 5 /PRNewswire/ -- Arthrosurfa...eloper of less-invasive joint,resurfacing systems,...U.S.,FDA to begin its pivotal investigation for it... stated that "there are no outstanding safety,conc...tion., Arthrosurface has been evaluating the safe...

(Date:9/5/2008)...e National Institute of Diabetes and Digestive and...titutes of Health (NIH), announces awards to eight...e studies of urologic chronic pelvic pain disorder...state. The total research investment for the five-...n. , "The launch of this novel research effort i...

(Date:9/5/2008)...DLOTHIAN, Va., Sept. 5 /PRNewswire/ -- On Saturday...featured on the Oxygen Network show Today,s,Family... highlighted as a,leading medical device company t...h effective nebulizers and compressors that delive... vision is to improve the lives of those affected ...

Breaking Medicine News(10 mins):Health News:No Place Safe From Allergies 2 Health News:Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage 2 Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 2 Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 3 Health News:PARI Respiratory Equipment Featured on Oxygen Network 2

[0] No Place Safe From Allergies [0] Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage [0] NIH launches unique effort to advance study of urologic chronic pelvic pain disorders [0] PARI Respiratory Equipment Featured on Oxygen Network

...y said it had got the go-ahead from Nigerian autho...e lives of 11 children in the northern Kano state ...(Nigeria's drug agency), the federal ministry of h...r guardians of the children before the clinical te...

...simple form of exercise that can keep blood pressu...ms or mental health in check - walking. So says M...n expert on obesity, who insists that all people ...eep healthy. "Getting out there and taking a wal...

...ome smokers have genetic predisposition to develop...he research from Wake Forest University School of ...some people increases their chances of developing ...cco. "The genetic variant we studied seemed harml...

...ting a tattoo done of their lover's initials due t...good news - researchers have discovered a techniqu... or removed as per the wearer's choice. The new m... where particles are suspended in a biodegradable ...

Other Medicine News:Health News:Walking Really is the Best Way to Keep Healthy 2 Health News:Genetic Variation in Some Smokers Increases Chances of Developing COPD 2

Pfizer Says Nigeria Gave Approval for 1996 Drug Test Walking Really is the Best Way to Keep Healthy Genetic Variation in Some Smokers Increases Chances of Developing COPD Now, a Tattoo That can Be Easily Removed

(Date:9/5/2008)...Extracted From a Simple Blood Draw Have,the Potent...a Wide Range of Indic...Genomics is Currently Developing a B...Israel and JERSEY CITY, New Jersey, September 5,/P...SDQ: ROSG), a leader in,the development of microRN...

(Date:9/4/2008)...eal-time PCR testing for the diagnostic ...ept. 4 /- The U.S. Food & Drug,Admini...Man(R) HBV Test,the first assay for quantitating ...t uses Roche,s real-time PCR technology to quantif...,s blood. Doctors may use viral load,testing resul...

(Date:9/4/2008)...Women at More Than 100 Sites in the U.S., ANN ARB...uticals, a,privately-held biopharmaceutical compan...compounds to treat endocrine, metabolic and,cardio...itiated a second,Phase 3 clinical trial of Ophena(...ree oral therapy in development for the treatment ...

(Date:9/4/2008)...tification for Targeted Therapies Tha...TINGTON BEACH, Calif., and AMSTERDAM, Netherlands,...n molecular cancer diagnostics,today announced th...that,allows physicians to quantitatively determine...or (ER), progesterone receptor (PR) and Human Epid...

[0] Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum [0] FDA Approves First Hepatitis B Viral Load Test [0] QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome [0] Agendia Launches TargetPrint(R) for Breast Cancer Patients

...ech (ACTI.ST), today,announced new positive clinic...reatment of prostate cancer. , By step-wise dose e...ieved, which corresponds to a doubling of the prev... of 0.5 mg/day. This,means that a step-wise intra-... to be administered in future clinical trials. , "...

...eragenix Pharmaceuticals,Inc. (OTCBB:CGXP), a bio...se and dermatology, today announced that a cathete...irtually no biofilm,formation in a 21 day study., ...Ceragenins,were soaked daily in a phosphate-suffer...ay 21, the catheters were challenged with,an inocu...

Other Medicine Technology:Positive Clinical Data for TASQ - Active Biotech's Novel Treatment,of Prostate Cancer 2 Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 2 Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 3

Positive Clinical Data for TASQ - Active Biotech's Novel Treatment,of Prostate Cancer Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study

Products	Integrated Shoulder System
Company	Biomet Orthopedics, Inc
Item	Integrated Shoulder System
Features
Description	Comprehensive, unified system for total or hemi shoulder arthroplasty.
Info	Biomet Orthopedics, Inc Customer Service: (800) 348-9500 Web site: http://www.biomet.com